• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Alcon partners with NFL star Cooper Kupp on eye allergy campaign

Article

The new partnership supports Alcon's Pataday Once Daily Relief Extra Strength eye drops as treatment for eye allergies.

Alcon and Cooper Kupp, a wide receiver on the NFL's Los Angeles Rams team, have partnered on a new campaign spotlighting eye allergy treatment, the company announced Monday.

Cooper Kupp

Image courtesy of @cooperkupp via Instagram


The partnership supports Alcon's Pataday Once Daily Relief Extra Strength, which is the first 24-hour allergy itch relief eye drop available in the US without a prescription.

Kupp will participate in the "The Right Tool for the Job" full-scale media campaign, which will highlight his personal history of eye allergy symptoms and seeking relief treatment with Alcon's product, as well as encourage consumers to use the drops for their own eyeallergy relief.

Alcon's Pataday Once Daily Relief Extra Strength

Image courtesy of Alcon

In a statement, he shared how seasonal allergy flare ups and pollen have often lead to him suffering from itchy eyes—a distraction during training camp and on the field during games. The drops have since allowed him to control his symptoms.

As an antihistamine eye drop, Pataday works by offering fast and long-lasting allergy itch relief to those experiencing allergic conjunctivits, according to the company.

Related Videos
Andy Morgenstern, OD, FAAO, FNAP chats with Optometry Times
R Tracy Williams, OD, FAAO with Optometry Times
Shan Lin, MD, speaks on Glaucoma 360 presentation in an interview with Ophthalmology Times
Cecelia Koetting, OD, FAAO, DIPABO, left, speaks with Optometry Times about the 2024 EnVision Summit
Bonnie An Henderson, MD, highlights key takeaways of the 2024 EnVision Summit, including diversity and family inclusion
Danica Marrelli, OD, FAAO, AAO Dipl, co-chair of EnVision Summit chats about geographic atrophy and glaucoma panels
Robert Weiss, former CEO and President of The Cooper Companies, Inc. (left) and Optometry Times' Assistant Managing Editor Emily Kaiser Maharjan Image Credit ©Optometry Times
© 2024 MJH Life Sciences

All rights reserved.